~~<i id='17616B60D1'><strike id='17616B60D1'><tt id='17616B60D1'><pre id='17616B60D1'></pre></tt></strike></i>~~

Home» knowledge» entertainment

entertainment

author：explore 2025-09-28 09:36:25 Page View：8772

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaysia cuts short music fest after British band slams anti
Next article： ChatGPT in medicine: STAT answers readers' burning questions

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

What to know about Virgin Galactic's 1st mission taking paying customers to space

1:42TheVirginGalacticSpaceShipTwospaceplaneUnityreturnstoearthaboveSpaceportAmerica,nearTruthandCons

Guidelines to prevent youth baseball injuries need more muscle

Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

Statins reduce cardiovascular risk in people living with HIV

AstatinadayreducestheriskofheartdiseaseinyoungerpeoplelivingwithHIV,accordingtoanewstudypublishedSun